Connect Sign In
LabMind podcasts
Jonathan Genzen, MD, PhD (left), chief medical officer and senior director of governmental affairs, will lead the webinar, and Jonathan Carr, JD (right), compliance officer, will moderate a Q&A session. |
November 21, 2023 |
ARUP to Host Webinar to Discuss Impacts of the FDA’s Proposed Rule to Regulate Lab-Developed Tests ARUP experts seek to increase understanding of the FDA’s proposed rule to regulate lab-developed tests as medical devices and the impact on hospitals and patients during a webinar on November 29. |
From left, Greg Critchfield, Myriad Genetics and Sera Prognostics; Mark Poritz, Co-Diagnostics; Kyle Berg, Quansys Biosciences; Jared Bauer, Seek Labs; Tracy I. George, ARUP Laboratories; and Andrew Hemmert, bioMerieux. These panelists addressed challenges facing diagnostics companies during a discussion at the Utah Life Sciences Summit in Salt Lake City on November 9. |
November 10, 2023 | A panel discussion at the Utah Life Sciences Summit explored how the FDA’s proposed rule to further regulate laboratory-developed tests could slow advances in diagnostic medicine. |
AAV5 DetectCDx™ detects the presence of anti-AAV5 antibodies to aid in the selection of patients eligible for the treatment ROCTAVIAN™. |
November 10, 2023 |
EU Approval of AAV5 DetectCDx™ Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy ARUP has gained a Conformité Européenne (CE) mark for AAV5 DetectCDx™ single-site use. The test will aid in determining the eligibility of non-U.S. patients for a new hemophilia A gene therapy. |
Founding members of the new Institute for Research and Innovation in Diagnostic and Precision MedicineTM collaborate. From left, Erica Clyde, MBA; Robert S. Ohgami, MD, PhD, FCAP; and Hunter Best, PhD, FACMG. |
November 9, 2023 |
ARUP to Highlight Molecular Pathology Advances at Annual Association for Molecular Pathology Meeting ARUP experts in molecular pathology will present at, participate in, and be available to attendees during the upcoming Association for Molecular Pathology (AMP) Meeting and Expo in Salt Lake City. |
ARUP’s Section Chief of Transfusion Medicine and Medical Director of the Transfusion Service, Ryan Metcalf, MD, contributed to recently updated guidelines for red blood cell transfusion by the Association for the Advancement of Blood and Biotherapies (AABB). |
November 7, 2023 |
New AABB Guidelines Recommend a Restrictive Red Blood Cell Transfusion Strategy The Association for the Advancement of Blood and Biotherapies recommends that providers use a restrictive transfusion strategy to reduce unnecessary transfusions and the risk of adverse events. |
ARUP embraces emerging technologies like artificial intelligence, machine learning, and digital pathology to optimize laboratory operations. |
November 6, 2023 |
ARUP Sponsors and Presents at the PLUGS Regional Summit in Los Angeles ARUP’s David P. Ng, MD, will share a presentation on artificial intelligence (AI) in the clinical lab at the Patient-centered Laboratory Utilization Guidance Services (PLUGS) Regional Summit. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat